You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Altria reported third-quarter adjusted diluted EPS growth of 4.8%, raised full-year guidance to $5.66 to $5.74, authorized a $1 billion share repurchase expansion, and expanded plus 12 milligram nicotine pouches nationally while adding flavor extensions.
Altria Group, Inc. established an automatic shelf registration allowing sales from time to time of debt securities and debt warrants in an unlimited amount; Philip Morris USA Inc. may guarantee the debt securities.
For the nine months ended September 30, 2026, Altria reported net earnings attributable to Altria of $6,999 million and diluted EPS of $4.18, increases of 20.1% and 21.2%, respectively.
Altria Group, Inc. raised 2026 full-year adjusted diluted EPS guidance to $5.66 to $5.74, representing growth of 4.5% to 6.0% from $5.42 in 2025. Third-quarter adjusted diluted EPS rose 4.8% to $1.52, and the Board expanded repurchases by $1 billion.
Altria Group, Inc. extended its $3.0 billion senior unsecured 5-year revolving credit agreement, effective October 7, 2026, moving expiration from October 24, 2029 to October 24, 2030; all other terms remain in force.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Altria delivered adjusted EPS growth of 4.8% in Q3, raised full-year adjusted diluted EPS guidance to $5.66-$5.74, expanded smokeable income and margins, grew on! volumes, and returned substantial cash to shareholders. Pressures included weaker cigarette volumes and Marlboro share, oral-tobacco earnings and margin contraction, on! nicotine-pouch share weakness, regulatory and litigation risks, and NJOY ACE remaining absent from the marketplace in 2026.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| 2026 Adjusted Diluted EPS non-GAAP | $1.48 | For the three months ended June 30, 2026 filing | — |
| 2026 Adjusted Net Earnings non-GAAP | $2.48B | For the three months ended June 30, 2026 filing | — |
| Adjusted OCI non-GAAP | $896M | Six Months Ended June 30, 2026 | — |
| Adjusted OCI margin non-GAAP | 66.7% | the three months ended June 30, 2026 filing | — |
| Copenhagen retail share | 13.4% | Six Months Ended June 30, 2026 | — |
| Copenhagen shipment volume | 165.8M | Six Months Ended June 30, 2026 | — |
| on! retail share | 8.2% | Six Months Ended June 30, 2026 | — |
| on! shipment volume | 96.1M | Six Months Ended June 30, 2026 | — |
| Other oral tobacco shipment volume | 16.9M | the three months ended June 30, 2026 filing | — |
| Other retail share | 2.2% | the three months ended June 30, 2026 filing | — |
| Skoal retail share | 5.2% | Six Months Ended June 30, 2026 | — |
| Skoal shipment volume | 57.4M | Six Months Ended June 30, 2026 | — |
| Total cigars shipment volume | 907M | Six Months Ended June 30, 2026 | — |
| Total domestic cigarettes shipment volume | 29.42B | Six Months Ended June 30, 2026 | — |
| Total domestic smokeable products shipment volume | 30.33B | Six Months Ended June 30, 2026 | — |
| Total oral tobacco products retail share | 29% | Six Months Ended June 30, 2026 | — |
| Total oral tobacco products shipment volume | 351.6M | Six Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MO
this stock
Altria Group, Inc.
|
$129.76B | +34.5% | -3.1% | 16.1 | 2.4% |
|
PM
Philip Morris International Inc.
|
$321.15B | +25.6% | +7.3% | 30.1 | 1.1% |
|
BTI
British American Tobacco p.l.c.
|
$135.30B | +11.4% | — | — | 0.1% |
|
RLX
RLX Technology Inc.
|
$1.98B | -30.5% | +50.3% | — | 0.7% |
|
TPB
Turning Point Brands, Inc.
|
$1.35B | -37.8% | +28.4% | 21.7 | 16.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Altria Group, Inc. raised 2026 full-year adjusted diluted EPS guidance to $5.66 to $5.74, representing growth of 4.5% to 6.0% from $5.42 in 2025. Third-quarter adjusted diluted EPS rose 4.8% to $1.52, and the Board expanded repurchases by $1 billion.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MO | +1.1% | +8.6% | +6.1% | -0.6% | +34.6% |
| SPY | -4.7% | -5.3% | -0.8% | -3.0% | +7.5% |
| vs SPY | +5.8% | +13.9% | +7.0% | +2.4% | +27.1% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
